197 related articles for article (PubMed ID: 21131601)
41. Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor.
Noh H; Kim HJ; Yu MR; Kim WY; Kim J; Ryu JH; Kwon SH; Jeon JS; Han DC; Ziyadeh F
Lab Invest; 2012 Nov; 92(11):1583-96. PubMed ID: 22964853
[TBL] [Abstract][Full Text] [Related]
42. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
Luo K; Lodish HF
EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
[TBL] [Abstract][Full Text] [Related]
43. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
Chen X; Wang H; Liao HJ; Hu W; Gewin L; Mernaugh G; Zhang S; Zhang ZY; Vega-Montoto L; Vanacore RM; Fässler R; Zent R; Pozzi A
J Clin Invest; 2014 Aug; 124(8):3295-310. PubMed ID: 24983314
[TBL] [Abstract][Full Text] [Related]
44. Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota.
Chuang LY; Guh JY; Liu SF; Hung MY; Liao TN; Chiang TA; Huang JS; Huang YL; Lin CF; Yang YL
Biochem J; 2003 Oct; 375(Pt 2):385-93. PubMed ID: 12841849
[TBL] [Abstract][Full Text] [Related]
45. Albumin endocytosis in endothelial cells induces TGF-beta receptor II signaling.
Siddiqui SS; Siddiqui ZK; Malik AB
Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L1016-26. PubMed ID: 14729511
[TBL] [Abstract][Full Text] [Related]
46. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
[TBL] [Abstract][Full Text] [Related]
47. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
[TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
49. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK.
Bakkebø M; Huse K; Hilden VI; Smeland EB; Oksvold MP
BMC Immunol; 2010 Nov; 11():57. PubMed ID: 21092277
[TBL] [Abstract][Full Text] [Related]
50. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
[TBL] [Abstract][Full Text] [Related]
52. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
[TBL] [Abstract][Full Text] [Related]
53. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
[TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
55. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.
Zuo W; Huang F; Chiang YJ; Li M; Du J; Ding Y; Zhang T; Lee HW; Jeong LS; Chen Y; Deng H; Feng XH; Luo S; Gao C; Chen YG
Mol Cell; 2013 Feb; 49(3):499-510. PubMed ID: 23290524
[TBL] [Abstract][Full Text] [Related]
56. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
57. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
59. Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function.
Feldman G; Kiely B; Martin N; Ryan G; McMorrow T; Ryan MP
J Am Soc Nephrol; 2007 Jun; 18(6):1662-71. PubMed ID: 17460148
[TBL] [Abstract][Full Text] [Related]
60. Expression and function of TbetaRII-B, a variant of the type II TGF-beta receptor, in human chondrocytes.
Parker WL; Finnson KW; Soe-Lin H; Knaus P; Philip A
Osteoarthritis Cartilage; 2007 Apr; 15(4):442-53. PubMed ID: 17175180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]